Skip to main content
رجوع
AVBP logo

ArriVent BioPharma, Inc. Common Stock

جودة البيانات: 100%
AVBP
NASDAQ Healthcare Biotechnology
KWD 22.18
▲ KWD 0.16 (0.73%)
القيمة السوقية: 980.39M
نطاق اليوم
KWD 21.73 KWD 22.72
نطاق 52 أسبوعًا
KWD 15.47 KWD 27.22
حجم التداول
483,405
متوسط 50 يوم / 200 يوم
KWD 22.89 / KWD 21.19
الإغلاق السابق
KWD 22.02

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -5.9 0.4
P/B 3.2 2.9
ROE % -58.9 3.8
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.0 0.2

النقاط الرئيسية

Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -160.59M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-58.88%
ROIC-43.34%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.00
Current Ratio12.83
Interest Coverage0.00

التقييم

P/E Ratio
-5.90
P/B Ratio3.19
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -166.31M
ROE -58.88% ROA -49.92%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -160.59M
ROIC -43.34% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 12.83
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -5.90 P/B Ratio 3.19
P/S Ratio N/A PEG Ratio -0.07
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 980.39M Enterprise Value 934.87M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -166.31M -80.49M -69.33M -36.91M -51.61M
EPS (Diluted) -4.32 -2.56 -2.17 -1.10 -40.44
Gross Profit 0.0 0.0 0.0 0.0 0.0
Operating Income -177.53M -94.31M -74.59M -36.91M -8.70M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 333.17M 274.94M 163.10M 182.83M 43.04M
Total Liabilities 25.95M 17.29M 11.80M 8.37M 1.82M
Shareholders' Equity 307.22M 257.65M 151.30M 174.46M 41.22M
Total Debt 14,000.0 176,000.0 317,000.0 139,000.0 0.0
Cash & Equivalents 45.54M 74.29M 150.39M 163.37M 37.28M
Current Assets 332.90M 226.98M 159.97M 182.62M 42.95M
Current Liabilities 25.95M 17.27M 11.62M 8.36M 1.82M